CRANIOMAX
0828.651.697 · rovalta.com · 25/09/2026
CRANIOMAX
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBOCRANIOMAX is a Private limited company incorporated in 2010. Its main activity is: Specialist medical practice activities. Its registered office is in Uccle. It employs on average 0,8 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0828.651.697
- Incorporation
- 23/08/2010
- Legal form
- Private limited company
- Registered office
- Avenue de la Ferme Rose 13 box 1
1180 Uccle · BruxellesSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2024
- Average workforce
- 0,8 ETP
Joint committees (1)
- 330
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 262,7 k € | -16.4% | 314,2 k € | +98.2% | 158,5 k € | -51.1% | 324 k € | +56.8% | 206,7 k € |
| EBITDA | 223,3 k € | -20.3% | 280,3 k € | +132% | 121,1 k € | -58.7% | 292,9 k € | +47.7% | 198,3 k € |
| Operating result | 119,1 k € | -37.9% | 191,7 k € | +289% | 49,3 k € | -79.1% | 236,2 k € | +49.1% | 158,4 k € |
| Net result | 45,5 k € | -67.0% | 137,8 k € | +491% | 23,3 k € | -81.6% | 126,7 k € | +18.9% | 106,5 k € |
| Balance sheet | |||||||||
| Equity | 526,7 k € | +9.4% | 481,2 k € | +11.0% | 433,4 k € | -1.1% | 438,1 k € | +40.7% | 311,5 k € |
| Total assets | 1 M € | -11.5% | 1,1 M € | +28.1% | 894,9 k € | -7.9% | 971,5 k € | +33.9% | 725,5 k € |
| Cash | 6,6 k € | +15.9% | 5,7 k € | -10.5% | 6,4 k € | -34.9% | 9,8 k € | -67.7% | 30,4 k € |
| Debts | 487,6 k € | -26.7% | 665,1 k € | +44.1% | 461,4 k € | -11.9% | 523,8 k € | +26.5% | 414 k € |
| Other | |||||||||
| Workforce | 0,8 ETP | – | – | – | 0,2 ETP | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20241 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
Avenue de la Ferme Rose 13 1180 Uccle| Company | CBE no. |
|---|---|
| 0850.266.267 | |
SURGIMAX INC● Active | 0873.440.755 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 26/09/2025 | 07/01/2025 | 31/10/2023 | 30/11/2022 | 29/11/2021 | 16/12/2020 |
| General meeting | 26/09/2025 | 03/01/2025 | 12/05/2023 | 30/11/2022 | 29/11/2021 | 15/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 26/09/2025 | 26/09/2025 | French | |
| Abridged model | 31/12/2023 | 03/01/2025 | 07/01/2025 | French | |
| Abridged model | 31/12/2022 | 12/05/2023 | 31/10/2023 | French | |
| Abridged model | 31/12/2021 | 30/11/2022 | 30/11/2022 | French | |
| Abridged model | 31/12/2020 | 29/11/2021 | 29/11/2021 | French | |
| Abridged model | 31/12/2019 | 15/12/2020 | 16/12/2020 | French | |
| Abridged model | 31/12/2018 | 10/05/2019 | 13/11/2019 | French | |
| Abridged model | 31/12/2017 | 06/12/2018 | 06/12/2018 | French | |
| Abridged model | 31/12/2016 | 05/12/2018 | 06/12/2018 | French | |
| Abridged model | 31/12/2015 | 30/03/2018 | 06/04/2018 | French | |
| Abridged model | 31/12/2014 | 15/11/2017 | 01/12/2017 | French | |
| Abridged model | 31/12/2013 | 14/04/2016 | 18/11/2016 | French | |
| Abridged model | 31/12/2012 | 05/10/2013 | 08/07/2014 | French | |
| Abridged model | 31/12/2011 | 30/04/2013 | 09/07/2013 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 202445,5 k €↓
- 2023Annual accounts 2023137,8 k €↑
- 2022Annual accounts 202223,3 k €↓
- 2021Annual accounts 2021126,7 k €↑
- 2020Annual accounts 2020106,5 k €↑
- 2019Annual accounts 201925,4 k €↓
- 2018Annual accounts 201858,6 k €↑
- 2017Annual accounts 2017-20,1 k €↓
- 2016Annual accounts 201660,6 k €↑
- 2015Annual accounts 201511,5 k €↑
- 2014Annual accounts 20143,2 k €↓
- 2013Annual accounts 201345 k €↑
- 2012Annual accounts 201226,6 k €↑
- 2011Annual accounts 2011-18,3 k €
- 23/08/2010IncorporationPrivate limited company